Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

DCU world class “early-warning” research on cancer, diabetes and heart disease gets €22.5m boost

19.10.2005


Revolutionary new self-diagnostic devices to provide early warning of deadly and debilitating illnesses like cancer, diabetes and heart disease are the aim of a €22.5m Science Foundation Ireland research facility to be established at Dublin City University.



The Biomedical Diagnostics Institute will carry out cutting-edge research to develop this range of next-generation biomedical devices that will directly affect the quality of people’s lives worldwide over the next decades.

SFI will provide funding of €16.5m - the largest SFI funding ever granted in this kind of project - and six industrial partners will provide a further €6m through a scientific collaboration, positioning Ireland to make a major breakthrough in the €20 billion global diagnostics market.


The diagnostic devices and sensors will aim to detect minute concentrations of disease related molecules in biological samples like blood, saliva, and breath.

The programme led by DCU Professor Brian MacCraith will include top research scientists from Dublin City University, the Royal College of Surgeons, National University of Ireland, Galway and University College Cork.

They will use novel “markers” for human disease that can be detected by special consumer home-testing devices “well in advance of the onset of clinical symptoms,” says Professor MacCraith. “All the elements for a successful research environment have been put together. An exciting blend of scientists, teams, and industrial partners lends itself to a high probability of success.”

“Ultimately, the combined scientific challenge lies primarily in creating reliable, miniaturised systems in which the presence of very low concentrations of disease–related molecules in a sample of blood, urine, sweat, saliva and breath, can be detected with exquisite sensitivity, ” he added.

Launching the new research centre, the Minister for Enterprise and Employment Micheal Martin said: “These devices will detect life–threatening events long before a critical stage is reached. They will allow chronic diseases to be controlled more effectively, thereby reducing hospital stays and saving lives. In many cases, the devices will be linked via advanced communications technologies to monitoring services which will provide speedy expert assessment.”

The Medical and Device and Diagnostics sector represents a vibrant growth area within the Irish economy already, with over 40 companies in the field, including 13 of the top 25 medical device and diagnostics companies in the world. The sector now employs 22,000 and has been highlighted as of the areas in which Ireland can grow significantly.

At the launch, Dr William C Harris, Director General of SFI said this initiative would have far- reaching implications for the Irish economy. “The medical device and diagnostics sector represents a vibrant growth area – one in which Ireland can develop a position of competitive strength and critical mass.”

More than 50 scientists will be involved in the programme, the majority based at DCU with an additional 10 from the industrial partners.

There are five core scientific programmes led by three DCU Professors, Brian MacCraith, Robert Forster, and Richard O Kennedy, Professor Dermot Kenny of RCSI, and Professor Luke Lee from UC Berkley who will carry out an SFI funded research Professorship at DCU over the next five years.

The research will focus on the use of high sensitivity biochips for cancer detection and cardiac “wellness” as well as novel (blood) coagulation monitoring systems. This critical research programme has six industrial partners, Becton Dickinson and Company, Hospira Inc, Inverness Medical Innovations Inc, Analog Devices Incorporated, Amic AB and Enfer Technology Limited.

In 2004 Professor MacCraith’s research group won €5.6m from SFI to establish the initial team and carry out development work. Today’s announcement is for €16.5m from SFI initially, with the potential of further substantial additional SFI funding.

During the initial phase Professor MacCraith’s team has already made substantial progress giving Ireland a recognised leading role in sensor research. A new set of Intellectual Property principles has been developed to cover the commercialisation of discoveries. The new approach is based on an “inventor owns” model, with arrangements for shared discoveries, and a model which incentivises all parties.

Professor MacCraith says the IP principles fully protect DCU and partner interests as well the interests of Irish taxpayers who are ultimately providing most funding for the new centre.

Change in the way clinical services are delivered and in laboratory services as well as better-informed patients have resulted in a move to patient-centred care. These factors and pressure on costs have brought about a greater emphasis on primary care and reduced focus on hospitals to deliver clinical care.

In the longer term, the proposed research programme will lead to miniaturised devices that can be inserted inside the body for long periods to provide important information about the patient’s well-being using advanced e-health communications technology.

Another emerging area is the field of personalised medicine with tailored medical therapies devised after specific diagnosis of the genetic variation of the patient. The centre programme also includes key educational and outreach developments from primary to third level with health starter programmes for children, second level teacher and student internships, special undergraduate courses and a new postgraduate MSc in diagnostics.

Shane Kenny | alfa
Further information:
http://www.dcu.ie

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

IHP presents the fastest silicon-based transistor in the world

05.12.2016 | Power and Electrical Engineering

InLight study: insights into chemical processes using light

05.12.2016 | Materials Sciences

High-precision magnetic field sensing

05.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>